The Ibex Medical Analytics Galen platform has received Breakthrough Device Designation from FDA.
The Breast International Group, the European Organization for Research and Treatment of Cancer and the Alliance Foundation Trials groups are collaborating with Sanofi to initiate a pivotal trial of an oral selective estrogen receptor degrader (SERD) in the adjuvant setting.
As American life returns to a semblance of normalcy, it may be time for President Biden’s administration to prioritize building a national digital health infrastructure.
NCI needs more funding to increase its low success rate of NCI-funded grant applications, David A. Tuveson said in testimony before the House Committee on Appropriations.
Elisa M. Rodriguez was named chief diversity and equity officer for faculty at Roswell Park Comprehensive Cancer Center.
Pediatric oncologist A. Thomas Look, of the Dana-Farber Cancer Institute, was named the 2021 recipient of The Society of Memorial Sloan Kettering Prize.
The American Association for Cancer Research has announced its newest class of grant recipients.
The American Association for Cancer Research plans to provide a workshop on excellence in clinical trial implementation as part of the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program.
Seventy one NCI-designated cancer centers and partner organizations have issued a joint statement urging the nation’s physicians, parents, and young adults to get the human papillomavirus vaccination back on track.
A new initiative, Project Health Equality, aims to address the structural and cultural barriers that prevent Black and Hispanic women in the U.S. from receiving the same quality health care as white women.
